CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-06 | GOREVIC JASON N Chief Executive Officer | Sale | −30,000 | $222.26 | $6.7M | 667,283 |
| 2020-10-06 | GOREVIC JASON N Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −30,000 | 310 | ||
| 2020-10-05 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +1,446 | $22.30 | $32K | 1,646 |
| 2020-10-05 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +1,164 | $38.55 | $45K | 2,810 |
| 2020-10-05 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −2,610 | $222.46 | $581K | 200 |
| 2020-10-05 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Employee Stock Option (right to buy) | −1,446 | 7,234 | ||
| 2020-10-05 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Employee Stock Option (right to buy) | −1,164 | 19,798 | ||
| 2020-10-05 | Turitz Andrew SVP - Business Development | Option exercise | +1,389 | $22.30 | $31K | 5,404 |
| 2020-10-05 | Turitz Andrew SVP - Business Development | Sale | −1,389 | $222.46 | $309K | 4,015 |
| 2020-10-05 | Turitz Andrew SVP - Business Development | Option exercise · Employee Stock Option (right to buy) | −1,389 | 6,945 | ||
| 2020-10-02 | Turitz Andrew SVP - Business Development | Option exercise | +717 | $38.55 | $28K | 4,732 |
| 2020-10-02 | Turitz Andrew SVP - Business Development | Sale | −717 | $225.00 | $161K | 4,015 |
| 2020-10-02 | Turitz Andrew SVP - Business Development | Option exercise · Employee Stock Option (right to buy) | −717 | 12,183 | ||
| 2020-10-01 | Levy Lewis Chief Medical Officer | Option exercise | +1,395 | $35.45 | $49K | 10,161 |
| 2020-10-01 | Levy Lewis Chief Medical Officer | Option exercise | +1,275 | $38.55 | $49K | 11,436 |
| 2020-10-01 | Levy Lewis Chief Medical Officer | Sale | −2,670 | $222.86 | $595K | 8,766 |
| 2020-10-01 | Levy Lewis Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −1,395 | 13,463 | ||
| 2020-10-01 | Levy Lewis Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −1,275 | 21,439 | ||
| 2020-10-01 | Verstraete Stephany Chief Marketing Officer | Option exercise | +6,000 | $22.30 | $134K | 19,276 |
| 2020-10-01 | Verstraete Stephany Chief Marketing Officer | Sale | −6,000 | $222.86 | $1.3M | 13,276 |
Page 88 of 93 · 1,848 trades